Shah, N. N., Merchant, M. S., Cole, D. E., Jayaprakash, N., Bernstein, D., Delbrook, C., . . . Wayne, A. S. (2016). Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias. Pediatric blood & cancer, 63(6), 997-1005. https://doi.org/10.1002/pbc.25937
Chicago-Zitierstil (17. Ausg.)Shah, Nirali N., Melinda S. Merchant, Diane E. Cole, Nalini Jayaprakash, Donna Bernstein, Cindy Delbrook, Kelly Richards, Brigitte C. Widemann, und Alan S. Wayne. "Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias." Pediatric Blood & Cancer 63, no. 6 (2016): 997-1005. https://doi.org/10.1002/pbc.25937.
MLA-Zitierstil (9. Ausg.)Shah, Nirali N., et al. "Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®): Results From a Phase I Study in Children, Adolescents, and Young Adults With Refractory Solid Tumors or Leukemias." Pediatric Blood & Cancer, vol. 63, no. 6, 2016, pp. 997-1005, https://doi.org/10.1002/pbc.25937.